WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SAGE

Based on 15 analysts offering 12 month price targets for Sage Therapeutics Inc.
Min Forecast
$20.00+2.25%
Avg Forecast
$29.87+52.69%
Max Forecast
$70.00+257.87%

Should I buy or sell SAGE stock?

Based on 15 analysts offering ratings for Sage Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
3 analysts 20%
Hold
12 analysts 80%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SAGE stock forecasts and price targets.

SAGE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Bank of America
Top 22%
79
HoldMaintains$24.00+22.70%2023-09-08
Mizuho
Top 3%
98
HoldMaintains$20.00+2.25%2023-09-07
RBC Capital
Top 8%
93
HoldMaintains$22.00+12.47%2023-09-07
Goldman Sachs
Top 20%
81
HoldMaintains$22.00+12.47%2023-08-09
Morgan Stanley
Bottom 11%
11
HoldMaintains$20.00+2.25%2023-08-09
TD Cowen
Bottom 2%
2
BuyMaintains$28.00+43.15%2023-08-08Find out why
Oppenheimer
Top 5%
96
HoldMaintains$20.00+2.25%2023-08-08
Truist Securities
Top 13%
88
HoldMaintains$20.00+2.25%2023-08-08Find out why
Canaccord Genuity
Bottom 9%
9
HoldDowngrades$21.00+7.36%2023-08-08Find out why
HC Wainwright & Co.
Bottom 9%
9
HoldMaintains$27.00+38.04%2023-08-08Find out why

1 of 2

Forecast return on equity

Is SAGE forecast to generate an efficient return?
Company
N/A
Industry
0.91%
Market
28.82%

Forecast return on assets

Is SAGE forecast to generate an efficient return on assets?
Company
N/A
Industry
0.07%

SAGE revenue growth forecast

How is SAGE forecast to perform vs Biotechnology companies and vs the US market?
Company
259.74%
Industry
35.95%
Market
8.15%
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SAGE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SAGE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAGE$19.56$29.87+52.69%Hold
KNSA$16.64$32.00+92.31%Strong Buy
MIRM$30.72$72.33+135.46%Strong Buy
DAWN$13.38$37.00+176.53%Buy
BHVN$16.93$27.50+62.43%Strong Buy
View Top Biotech Stocks

Sage Therapeutics Stock Forecast FAQ

Is Sage Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NASDAQ: SAGE) stock is to Hold SAGE stock.

Out of 15 analysts, 0 (0%) are recommending SAGE as a Strong Buy, 3 (20%) are recommending SAGE as a Buy, 12 (80%) are recommending SAGE as a Hold, 0 (0%) are recommending SAGE as a Sell, and 0 (0%) are recommending SAGE as a Strong Sell.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.

What is SAGE's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: SAGE) forecast ROE is N/A, which is considered weak.

What is SAGE's Price Target?

According to 15 Wall Street analysts that have issued a 1 year SAGE price target, the average SAGE price target is $29.87, with the highest SAGE stock price forecast at $70.00 and the lowest SAGE stock price forecast at $20.00.

On average, Wall Street analysts predict that Sage Therapeutics's share price could reach $29.87 by Sep 8, 2024. The average Sage Therapeutics stock price prediction forecasts a potential upside of 52.69% from the current SAGE share price of $19.56.

What is SAGE's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: SAGE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.